Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Kasparek Anne-Katrin |

Publications

** = Publications listed in SCI/SSCI/Pubmed

2021

Full paper/article (Journal)

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2020

Full paper/article (Journal)

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2019

Full paper/article (Journal)

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2018

Abstract (Journal)

** Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

Abstract (Proceedings)

** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

2017

Full paper/article (Journal)

** Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36 Doi: 10.5301/tj.5000696
Web of Science PubMed FullText FullText_MUG

** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061 Doi: 10.18632/oncotarget.21647 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2015

Full paper/article (Journal)

** Aigner, B; Kornprat, P; Schöllnast, H; Kasparek, AK; Mischinger, HJ; Haybaeck, J A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications.
Anticancer Res. 2015; 35(9):4821-4828 (- Case Report)
Web of Science PubMed

2014

Abstract (Journal)

** Keil, F; Selzer, E; Berghold, A; Reinisch, S; de Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsasser, W; Kainz, H; Riedl, R; Kapp, K; Kopp, M; Kornek, G Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
ONCOL RES TREAT. 2014; 37: 273-273.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie.; Oct 10-14, 2014; Hamburg, Deutschland. [Oral Communication]
Web of Science

2013

Full paper/article (Journal)

** Andritsch, E; Stöger, H; Bauernhofer, T; Andritsch, H; Kasparek, AK; Schaberl-Moser, R; Ploner, F; Samonigg, H The ethics of space, design and color in an oncology ward.
Palliat Support Care. 2013; 11(3):215-221 Doi: 10.1017/S1478951512000077
Web of Science PubMed FullText FullText_MUG

** Keil, F; Selzer, E; Berghold, A; Reinisch, S; Kapp, KS; De Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsäßer, W; Kainz, H; Riedl, R; Kopp, M; Kornek, G Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Eur J Cancer. 2013; 49(2):352-359 Doi: 10.1016/j.ejca.2012.08.004
Web of Science PubMed FullText FullText_MUG

2010

Full paper/article (Journal)

** Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Gallè, G; Samonigg, H; Hofmann, G Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.
Onkologie. 2010; 33(8-9):452-454 Doi: 10.1159/000317269 (- Case Report)
Web of Science PubMed FullText FullText_MUG

2000

Abstract (Journal)

** Kuss, I; Wagner, P; Genser, B; Stöger, H; Kasparek, AK; Samonigg, H Low dose weekly anthracycline chemotherapy for breast cancer patients with bone marrow infiltration.
ANN ONCOL 2000 11: 38-38.
Web of Science

1999

Review

** Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268 Doi: 10.1159/000012058 (- Case Report)
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science

1994

Full paper/article (Journal)

** Stöger, H; Bauernhofer, T; Kasparek, AK; Schmid, M; Moser, R; Ploner, F; Derstvenscheg, E; Kuss, I; Wilders-Truschnig, M; Steindorfer, P Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1994; 34(1):75-78 Doi: 10.1007/BF00686116
Web of Science PubMed FullText FullText_MUG

** Stöger, H; Schmid, M; Bauernhofer, T; Moser, R; Ploner, F; Derstvenscheg, E; Kasparek, AK; Kuss, I; Wilders-Truschnig, M; Lackner, C A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Oncology. 1994; 51(6):518-522 Doi: 10.1159/000227397
Web of Science PubMed FullText FullText_MUG Google Scholar

** Zweiker, R; Eber, B; Samonigg, H; Reisinger, EC; Kasparek, A; Schumacher, M; Fruhwald, FM; Apfelbeck, U; Klein, W Toxoplasmosis peri-myocarditis as initial manifestation of highly malignant non-Hodgkin's lymphoma
Z Kardiol. 1994; 83(3):234-237 (- Case Report)
Web of Science PubMed

1991

Full paper/article (Journal)

** Samonigg, H; Stöger, H; Kasparek, AK; Schmid, M; Dusleag, J; Pfeiffer, K; Smola, M; Steindorfer, P; Lechner, P Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Cancer Chemother Pharmacol. 1991; 27(6):477-480 Doi: 10.1007/BF00685163
Web of Science PubMed FullText FullText_MUG Google Scholar

1990

Full paper/article (Journal)

** Samonigg, H; Kasparek, AK; Stöger, H; Schmid, M; Eber, B; Stark, G; Weinrauch, V; Pfeiffer, K; Smola, M; Steindorfer, P 4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1990; 26(4):293-296 Doi: 10.1007/BF02897233
Web of Science PubMed FullText FullText_MUG Google Scholar

** Samonigg, H; Stöger, H; Bauernhofer, T; Schmid, M; Kasparek, AK; Kuss, I; Kaul, M; Heberle, U; Vieder, L; Dusleag, J Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results).
Am J Clin Oncol. 1990; 13 Suppl 1(4):S44-S47 Doi: 10.1097/00000421-199012001-00010
Web of Science PubMed FullText FullText_MUG Google Scholar

** Stark, G; Stark, U; Samonigg, H; Kasparek, K; Lueger, A; Nagl, S; Bertuch, H; Pilger, E; Tritthart, HA Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts.
Cancer Chemother Pharmacol. 1990; 26(6):415-418 Doi: 10.1007/BF02994091
Web of Science PubMed FullText FullText_MUG Google Scholar

1988

Abstract (Journal)

** SAMONIGG, H; SCHEITHAUER, W; DEPISCH, D; WIEGELE, J; SCHULLER, J; HAUSMANNINGER, H; LUDWIG, H; STOGER, H; PREIS, P; KASPAREK, AK; ZIELINSKI, C PHASE-II STUDY - PIRARUBICIN (4-O-TETRAHYDRO-PYRANYL-ADRIAMYCIN THP) IN ADVANCED BREAST-CANCER
BLUT. 1988; 57(4): 206-206.
Web of Science

1987

Abstract (Journal)

** SAMONIGG, H; STOGER, H; KASPAREK, AK A PHASE-II-STUDY - COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE
BLUT. 1987; 55(4): 362-362.
Web of Science

** STOGER, H; KASPAREK, AK; SAMONIGG, H PREOPERATIVE POLYCHEMOTHERAPY WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE FOR INFLAMMATORY BREAST-CANCER
BLUT. 1987; 55(4): 363-363.
Web of Science

↑ Top of page / Navigation